Language : English
Published : 2018-03-15
Pages : 220
A Research Guide to Psychology: Print and Electronic Sources
This authoritative research guide uses a problem-solving approach to presenting print and electronic resources. Coverage includes: -Definition and deep background sources -Specialized dictionaries, encyclopedias, and handbooks -Current research – Journal Articles and Annual Reviews -Tests and Measures -Bibliographies -U.S. Government Resources -Biographical Resources -Directories and Organizations -Style Guides -Diagnostic Measures -Career Path and Educational Resources -Book Reviews -Major Museums and Archives
Pre-Order (3-4 weeks)
A sensitive and thorough approach to childhood behavior disorders.
Abnormal Child and Adolescent Psychology presents a comprehensive, research-based introduction to understanding child and adolescent psychopathology. The authors provide a logically formatted and easy to understand text that covers the central issues and theoretical and methodological foundations of childhood behavior disorders.
Rich with illustrations and examples, this text highlights the newest areas of research and clinical work, stressing supported treatments and the prevention of behavior problems of youth.
Upon completing this book, readers will be able to:
- Understand the psychological problems found in children and adolescents
- Understand methods of treatment and prevention for childhood behavior disorders
- Discuss issues related to childhood behavior disorders
About the Author
Daniel Kahneman is Eugene Higgins Professor of Psychology Emeritus at Princeton University and Professor of Psychology and Public Affairs Emeritus at Princeton’s Woodrow Wilson School of Public and International Affairs. He received the 2002 Nobel Prize in Economic Sciences for his pioneering work with Amos Tversky on decision-making.
A genuinely student-friendly and engaging introduction to work psychology and organisational behaviour. Packed with real life examples and ethical dilemmas to start debate and get students thinking critically, The Psychology of People in Organisations offers authoritative content presented in a refreshingly accessible way.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.